Page last updated: 2024-11-02

orphenadrine and Blepharospasm-Oromandibular Dyskinesia

orphenadrine has been researched along with Blepharospasm-Oromandibular Dyskinesia in 1 studies

Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rossi, B1
Vignocchi, G1
Siciliano, G1
Risaliti, R1

Other Studies

1 other study available for orphenadrine and Blepharospasm-Oromandibular Dyskinesia

ArticleYear
Effects of anticholinergic agents on the excitability of the blink reflex in Meige syndrome.
    European neurology, 1989, Volume: 29, Issue:5

    Topics: Aged; Basal Ganglia Diseases; Blinking; Female; Humans; Meige Syndrome; Middle Aged; Orphenadrine; P

1989